Alison Lawton
2019 - Kaleido Biosciences
In 2019, Alison Lawton earned a total compensation of $2.9M as President and Chief Executive Officer principal executive officer at Kaleido Biosciences, a 57% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $276,563 |
|---|---|
| Option Awards | $2,101,475 |
| Salary | $500,000 |
| Other | $11,196 |
| Total | $2,889,234 |
Lawton received $2.1M in option awards, accounting for 73% of the total pay in 2019.
Lawton also received $276.6K in non-equity incentive plan, $500K in salary and $11.2K in other compensation.
Rankings
In 2019, Alison Lawton's compensation ranked 4,241st out of 13,971 executives tracked by ExecPay. In other words, Lawton earned more than 69.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,241 out of 13,971 | 70th |
Division Manufacturing | 1,551 out of 5,701 | 73rd |
Major group Chemicals And Allied Products | 543 out of 2,200 | 75th |
Industry group Drugs | 455 out of 1,886 | 76th |
Industry Biological Products, Except Diagnostic Substances | 94 out of 389 | 76th |
Source: SEC filing on May 8, 2020.
Lawton's colleagues
We found four more compensation records of executives who worked with Alison Lawton at Kaleido Biosciences in 2019.